Patent · US Active

Ureas and their use in the treatment of heart failure

US8513257B2 · kind B2 · utility

27Cited by

37References

32Claims

0Family size

Assignee

CYTOKINETICS, INC. · US

Inventors

Bradley P. Morgan · Moraga, US
Alex Muci · South San Francisco, US
Pu-Ping Lu · Foster City, US
Erica Anne Kraynack · South San Francisco, US
Todd Tochimoto · Foster City, US
David J. Morgans, Jr. · Los Altos, US

Key dates

Filing date	Dec 30, 2011
Grant date	Aug 20, 2013
Priority date	—
Expiry date	Dec 30, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.